Change search
ReferencesLink to record
Permanent link

Direct link
Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensisstrain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria
Umeå University, Faculty of Science and Technology, Department of Mathematics and Mathematical Statistics. Umeå University, Faculty of Medicine, Department of Clinical Microbiology, Clinical Bacteriology. (Patrik Rydén CLiC)
Show others and affiliations
2013 (English)In: Molecular Immunology, ISSN 0161-5890, E-ISSN 1872-9142, Vol. 54, no 1, 58-67 p.Article in journal (Refereed) Published
Abstract [en]

Francisella tularensis subspecies tularensis is an extremely virulent facultative intracellular bacterial pathogen capable of causing significant mortality in humans when inhaled. Consequently, subspecies tularensis was developed as a biological weapon more than 50 years ago. To counter this threat the US Army empirically developed a live vaccine strain, F. tularensis LVS, from the less virulent holarctica subspecies. In human experiments LVS afforded substantial protection against transdermal challenge with clinical subspecies tularensis strain, SCHU S4, but lesser protection against infection initiated by inhalation of the pathogen. Several regulatory and clinical issues remain unresolved for this vaccine, including the absence of a robust correlate of protection. To try to address this, we have developed several defined gene deletion mutants of SCHU S4 that elicit varying degrees of protection in a mouse dermal or respiratory challenge model. In the present study, we have examined whether host immune responses to immunization with such live vaccine candidates can serve as correlates of protection. Antibody responses were unable to distinguish between effective and ineffective vaccine strains. However, several cytokine responses to vaccination showed some promise. Especially, serum levels of TNFα, IFNγ, and MCP-1 between days 4 and 7 after vaccination appear to correlate with protection against respiratory challenge.

Place, publisher, year, edition, pages
2013. Vol. 54, no 1, 58-67 p.
Keyword [en]
Francisella, Cytokines, Chemokines, Antibodies, Mutants
National Category
Microbiology in the medical area
URN: urn:nbn:se:umu:diva-62058DOI: 10.1016/j.molimm.2012.10.043PubMedID: 23201853OAI: diva2:574494
Available from: 2012-12-05 Created: 2012-12-05 Last updated: 2016-05-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Rydén, PatrikSjöstedt, Anders
By organisation
Department of Mathematics and Mathematical StatisticsClinical Bacteriology
In the same journal
Molecular Immunology
Microbiology in the medical area

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 124 hits
ReferencesLink to record
Permanent link

Direct link